Filing Details
- Accession Number:
- 0000899243-22-025989
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-07-12 17:27:46
- Reporting Period:
- 2022-07-11
- Accepted Time:
- 2022-07-12 17:27:46
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1756262 | Transmedics Group Inc. | TMDX | Electromedical & Electrotherapeutic Apparatus (3845) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1774272 | F John Carey | C/O Transmedics Group, Inc. 200 Minuteman Road Andover MA 01810 | Vp Of Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-07-11 | 1,500 | $16.14 | 1,879 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-07-11 | 1,500 | $32.98 | 379 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2022-07-11 | 1,500 | $0.00 | 1,500 | $16.14 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
6,625 | 2030-02-27 | No | 4 | M | Direct |
Footnotes
- The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.
- The reported is a weighted average price. These shares were sold in multiple transactions ranging from $32.60 to $33.49, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- The option vested and will continue to vest at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020. As of the date of this report, the option remains subject to vesting with respect to 6,250 shares.